PharmiWeb.com - Global Pharma News & Resources

Rexgenero

Research & Development

Rexgenero is a privately held, UK-based regenerative medicine company pioneering the development of patient-specific cell-based therapies to treat serious diseases such as chronic limb-threatening ischemia (CLI).